On Invalid Date, Aptorum Group (NASDAQ: APM) reported Q2 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Aptorum Group earnings for the quarter were N/A. In the same quarter last year, Aptorum Group's earnings per share (EPS) was N/A.
As of Q2 2024, Aptorum Group's earnings has grown year over year. Aptorum Group's earnings in the past year totalled -$13.40 million.
What is APM's earnings date?
Aptorum Group's earnings date is Invalid Date. Add APM to your watchlist to be reminded of APM's next earnings announcement.
What was APM's revenue last quarter?
On Invalid Date, Aptorum Group (NASDAQ: APM) reported Q2 2023 revenue of N/A up N/A year over year. In the same quarter last year, Aptorum Group's revenue was N/A.
What was APM's revenue growth in the past year?
As of Q2 2024, Aptorum Group's revenue has grown -16.18% year over year. This is 165.15 percentage points lower than the US Biotechnology industry revenue growth rate of 148.97%. Aptorum Group's revenue in the past year totalled $1.20 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.